Literature DB >> 20031337

Is the increase in LDL cholesterol induced by selective serotonin reuptake inhibitor therapy a blessing in disguise?

Mark R Goldstein, Luca Mascitelli, Francesca Pezzetta.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 20031337     DOI： 10.1016/j.mehy.2009.11.041

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN： 0306-9877            Impact factor:   1.538


× No keyword cloud information.
  1 in total

1.  HBK-14 and HBK-15 Do Not Influence Blood Pressure, Lipid Profile, Glucose Level, or Liver Enzymes Activity after Chronic Treatment in Rats.

Authors:  Karolina Pytka; Monika Głuch-Lutwin; Joanna Knutelska; Magdalena Jakubczyk; Anna Waszkielewicz; Magdalena Kotańska
Journal:  PLoS One       Date:  2016-10-27       Impact factor: 3.240
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.